Psychiatry and Neurology, Neurology · Tampa, FL
NPI
1992724736
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
3
Medicare group memberships
Hospitals
3
Hospital affiliations
14014 N 46th St Ste C
Tampa, FL, 33613
Phone (813) 971-8811
Groups this clinician bills Medicare through
Medicare paid, 2024
$123K
1,161 services
Medicare patients, 2024
773
Average age 76
Drug cost, 2024
$4.0M
4,948 prescriptions
Company payments, 2025
$2,010
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Edmund G Grant was code 99214 (office e&m - established), 734 times for 544 patients. In total Edmund G Grant billed 1,161 services in 17 codes, and Medicare paid $123K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-03-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 734 | 544 | $88.49 | $65K |
| 99204 Office E&M - New | Office | 167 | 167 | $112.38 | $19K |
| 99215 Office E&M - Established | Office | 130 | 112 | $129.45 | $17K |
| 95816 Neurologic | Office | 43 | 43 | $268.79 | $12K |
| 99205 Office E&M - New | Office | 42 | 42 | $137.18 | $5,762 |
| 99213 Office E&M - Established | Office | 12 | 12 | $46.92 | $563 |
By year: 2022 $160K for 1,431 services; 2023 $158K for 1,319 services; 2024 $123K for 1,161 services.
Medicare prescription drug claims, 2024
In 2024, the drug Edmund G Grant prescribed most often to Medicare patients was Donepezil Hcl, with 462 prescriptions and refills. In total Edmund G Grant wrote 4,948 Medicare prescriptions that cost $4.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Donepezil Hcl Generic | 462 | 981 | 141 | $6,190 |
| Memantine Hcl Generic | 418 | 960 | 135 | $12K |
| Carbidopa-Levodopa Carbidopa/Levodopa | 407 | 1,005 | 129 | $15K |
| Escitalopram Oxalate Generic | 247 | 567 | 81 | $3,013 |
| Gabapentin Generic | 243 | 640 | 86 | $6,176 |
| Clonazepam Generic | 233 | 402 | 63 | $2,692 |
| Lamotrigine Generic | 134 | 352 | 35 | $3,607 |
| Levetiracetam Generic | 130 | 353 | 43 | $4,273 |
| Alprazolam Generic | 118 | 183 | 43 | $775 |
| Gamunex-C Immune Globul G/Gly/Iga Avg 46 | 113 | 116 | 11 | $2.1M |
| Propranolol Hcl Er Propranolol Hcl | 113 | 281 | 34 | $3,921 |
| Divalproex Sodium Generic | 111 | 205 | 33 | $4,367 |
| Galantamine Er Galantamine Hbr | 103 | 243 | 29 | $8,241 |
| Duloxetine Hcl Generic | 91 | 179 | 28 | $2,318 |
| Propranolol Hcl Generic | 68 | 161 | 29 | $665 |
Brand drugs: 465 claims; generic drugs: 4,457 claims; opioid claims: 27.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Edmund G Grant $2,010 ($2,010 in general payments such as food, travel and fees) from 24 companies. The largest payer was Pfizer Inc. with $319.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 25 | $319 |
| UCB, Inc. UCB.BR | 10 | $201 |
| Celgene Corporation BMY | 8 | $188 |
| Neurocrine BioSciences, Inc. NBIX | 7 | $148 |
| ACADIA Pharmaceuticals Inc ACAD | 6 | $131 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 4 | $122 |
| Vanda Pharmaceuticals Inc. VNDA | 5 | $112 |
| Argenx US, Inc. ARGX | 3 | $104 |
| Abbvie Inc. ABBV | 4 | $96.23 |
| Cycle Pharmaceuticals Inc | 4 | $83.04 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.